Issued 2026-09-16 at $17.01 · now $17.01 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, SPH has typically landed between $15.54 and $18.81 — a range of −8.7% to +10.6% from the issuance price $17.01.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($17.01) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where SPH has typically landed a month from the 2026-09-16 close of $17.01 — the range is history, not a prediction.
- now $17.01 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $17.09 (+0.5%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $16.53–$17.65
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $15.54–$18.81
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-18 | −50.9% | −50.9% | +0.1% |
| 2020-02-19 | −50.0% | −50.8% | +0.3% |
| 2020-02-21 | −47.2% | −50.6% | +0.0% |
| 3 best | |||
| 2008-10-10 | +50.5% | +0.0% | +57.1% |
| 2008-10-09 | +45.1% | −4.5% | +50.0% |
| 2016-02-10 | +40.4% | +0.0% | +42.6% |
5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 | Koepke Bryon L | officer | Sale | 2,848 @ $17.65 | $50K | −2.8% of holding | not yet — horizon still open | not yet — horizon still open | 100,714 | Form 4 · filed 1 day after the trade |
| 2025-12-02 | Chanin Matthew J | director | Sale | 10,000 @ $19.31 | $193K | −13.7% of holding | −2.3% | −6.2% | 63,176 | Form 4 · filed 2 days after the trade |
| 2025-08-13 | LOGAN HAROLD R JR | director | Sale | 7,500 @ $18.66 | $140K | −19.1% of holding | −3.2% | +4.4% | 31,727 | Form 4 · filed 2 days after the trade |
| 2025-05-21 | LOGAN HAROLD R JR | director | Sale | 6,900 @ $19.14 | $132K | −15.0% of holding | −3.0% | −13.1% | 39,227 | Form 4 · filed same day |
| 2025-03-12 | Brinkworth Douglas | officer | Sale | 2,000 @ $20.50 | $41K | −1.2% of holding | +0.9% | −24.2% | 159,355 | Form 4 · filed 1 day after the trade |
| 2025-02-18 | Palleschi Craig | officer | Sale | 1,400 @ $22.03 | $31K | −6.4% of holding | +2.5% | −19.9% | 20,498 | Form 4 · filed 1 day after the trade |
| 2025-02-11 | Schueler Michael A | other | Sale | 7,746 @ $20.93 | $162K | −41.0% of holding | +3.7% | −15.9% | 11,133 | Form 4 · filed 2 days after the trade |
| 2024-12-05 | Brinkworth Douglas | officer | Sale | 5,971 @ $19.50 | $116K | −3.6% of holding | −5.3% | −3.2% | 161,355 | Form 4 · filed 4 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
116 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2025-11-19 | LOGAN HAROLD R JR | director | Disposition | 5,000 | 26,727 | Form 4 |
| 2025-11-15 | Cleffi Francesca | officer | Award / grant | 17,415 | 34,049 | Form 4 |
| 2025-11-15 | Koepke Bryon L | officer | Award / grant | 17,415 | 103,562 | Form 4 |
| 2025-11-15 | STIVALA MICHAEL A | director | Award / grant | 48,224 | 336,981 | Form 4 |
| 2025-11-15 | Centeno Alejandro | officer | Award / grant | 18,754 | 69,587 | Form 4 |
| 2025-11-15 | Cleffi Francesca | officer | Award / grant | 17,415 | 105,776 | Form 4 |
| 2025-11-15 | Brinkworth Douglas | officer | Award / grant | 24,112 | 49,064 | Form 4 |
| 2025-11-15 | DAMBROSIO A DAVIN | officer | Award / grant | 7,368 | 14,992 | Form 4 |
| 2025-11-15 | Scanlon Neil | officer | Award / grant | 21,433 | 43,612 | Form 4 |
| 2025-11-15 | Onderdonk Keith P | officer | Award / grant | 10,717 | 21,316 | Form 4 |
| 2025-11-15 | Sankara Nandini | officer | Award / grant | 10,717 | 21,316 | Form 4 |
| 2025-11-15 | Onderdonk Keith P | officer | Award / grant | 10,717 | 86,599 | Form 4 |
| 2025-11-15 | Bloomstein Daniel S | officer | Award / grant | 10,717 | 77,570 | Form 4 |
| 2025-11-15 | Centeno Alejandro | officer | Award / grant | 18,754 | 18,754 | Form 4 |
| 2025-11-15 | Bloomstein Daniel S | officer | Award / grant | 10,717 | 21,316 | Form 4 |
| 2025-11-15 | Dante Elmer | officer | Award / grant | 8,038 | 14,928 | Form 4 |
| 2025-11-15 | Koepke Bryon L | officer | Award / grant | 17,415 | 34,049 | Form 4 |
| 2025-11-15 | Kuglin Michael | officer | Award / grant | 24,112 | 198,182 | Form 4 |
| 2025-11-15 | Kuglin Michael | officer | Award / grant | 24,112 | 49,064 | Form 4 |
| 2025-11-15 | Palleschi Craig | officer | Award / grant | 8,038 | 15,417 | Form 4 |
| 2025-11-15 | Sankara Nandini | officer | Award / grant | 10,717 | 66,092 | Form 4 |
| 2025-11-15 | Dante Elmer | officer | Award / grant | 8,038 | 37,482 | Form 4 |
| 2025-11-15 | Scanlon Neil | officer | Award / grant | 21,433 | 180,403 | Form 4 |
| 2025-11-15 | DAMBROSIO A DAVIN | officer | Award / grant | 7,368 | 79,710 | Form 4 |
| 2025-11-15 | Palleschi Craig | officer | Award / grant | 8,038 | 24,949 | Form 4 |
| 2025-11-15 | Dagan Douglas | officer | Award / grant | 34,830 | 101,331 | Form 4 |
| 2025-11-15 | Brinkworth Douglas | officer | Award / grant | 24,112 | 171,469 | Form 4 |
| 2025-11-15 | STIVALA MICHAEL A | director | Award / grant | 16,075 | 31,290 | Form 4 |
| 2025-11-14 | Brinkworth Douglas | officer | Disposition | 23,403 | 147,357 | Form 4 |
| 2025-11-14 | Kuglin Michael | officer | Disposition | 23,403 | 174,070 | Form 4 |
| 2025-11-14 | Kuglin Michael | officer | Option exercise | 23,403 | 197,473 | Form 4 |
| 2025-11-14 | Brinkworth Douglas | officer | Option exercise | 23,403 | 170,760 | Form 4 |
| 2025-11-14 | STIVALA MICHAEL A | director | Withheld for tax | 22,442 | 288,757 | Form 4 |
| 2025-11-14 | Scanlon Neil | officer | Option exercise | 20,712 | 179,682 | Form 4 |
| 2025-11-14 | Scanlon Neil | officer | Disposition | 20,712 | 158,970 | Form 4 |
| 2025-11-14 | Cleffi Francesca | officer | Option exercise | 15,331 | 103,692 | Form 4 |
| 2025-11-14 | Dagan Douglas | officer | Disposition | 15,331 | 66,501 | Form 4 |
| 2025-11-14 | Koepke Bryon L | officer | Option exercise | 15,331 | 101,478 | Form 4 |
| 2025-11-14 | Dagan Douglas | officer | Option exercise | 15,331 | 81,832 | Form 4 |
| 2025-11-14 | Cleffi Francesca | officer | Disposition | 15,331 | 88,361 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.